Sixty-six healthy adults with ( @ ( OH ) D ) < @ ng/mL were randomly assigned to take one of three D@ supplements , ie , a chewable tablet ( TAB ) , an oil-emulsified drop ( DROP ) , or an encapsulated powder ( CAP ) at a label-claimed dose of @,@ IU/day .